Jon P. Stonehouse
2021
Compensation breakdown
| Bonus | $43,762 |
|---|---|
| Non-Equity Incentive Plan | $492,324 |
| Option Awards | $4,511,089 |
| Salary | $583,495 |
| Stock Awards | $1,405,890 |
| Other | $24,665 |
| Total | $7,061,225 |
Stonehouse received $4.5M in option awards, accounting for 64% of the total pay in 2021.
Stonehouse also received $43.8K in bonus, $492.3K in non-equity incentive plan, $583.5K in salary, $1.4M in stock awards and $24.7K in other compensation.
Rankings
In 2021, Jon P. Stonehouse's compensation ranked 1,722nd out of 12,415 executives tracked by ExecPay. In other words, Stonehouse earned more than 86.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,722 out of 12,415 | 86th |
Division Manufacturing | 636 out of 5,505 | 88th |
Major group Chemicals And Allied Products | 235 out of 2,375 | 90th |
Industry group Drugs | 197 out of 2,096 | 91st |
Industry Biological Products, Except Diagnostic Substances | 55 out of 449 | 88th |
Pay ratio
| Jon P. Stonehouse's Pay | $7,061,225 |
|---|---|
| Median Employee's Pay | $273,522 |
| Pay Ratio | 26to 1 |
In 2021, the annual total compensation of Jon P. Stonehouse was $7,061,225.
The annual total compensation of the median employee at BioCryst Pharmaceuticals was $273,522.
The ratio of Jon P. Stonehouse's pay to the pay of median employee was therefore 26 to one.
Stonehouse's colleagues
We found five more compensation records of executives who worked with Jon P. Stonehouse at BioCryst Pharmaceuticals in 2021.
2021
Megan Sniecinski
BioCryst Pharmaceuticals
Former Chief Business Officer
2021
Helen Thackray
BioCryst Pharmaceuticals
Chief R&D Officer
2021
Anthony Doyle
BioCryst Pharmaceuticals
Chief Financial Officer
2021
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2021
Yarlagadda Babu
BioCryst Pharmaceuticals